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(57) ABSTRACT 
The invention involves a device and method for ascertaining 
the functioning of the respiratory system and, in particular, 
determining the cardiac output of a patient. The device 
comprises an apparatus containing sensors for measuring the 
oxygen and carbon dioxide concentrations as well as the 
volume of air inhaled and exhaled by a patient. The patient 
is provided a mouthpiece for breathing into and out of the 
device, which subsequently measures oxygen partial pres-
sures of the inhaled and exhaled air. In addition, the patient's 
arterial oxygen saturation is continuously measured through 
pulse oximetry and the pH and hemoglobin concentration is 
determined from a venous blood sample. From this data, the 
cardiac output of the patient may be calculated. 
8 Claims, 3 Drawing Sheets 
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NON-INVASIVE DEVICE AND METHOD FOR 
MEASURING THE CARDIAC OUTPUT OF A 
PATIENT 
CROSS REFERENCES TO RELATED 
APPLICATION 
2 
The present application is a divisional of Applicant's 
co-pending U.S. application Ser. No. 10/400,339, filed on 
Mar. 26, 2003, which is a divisional application of U.S. Pat. 
No. 6,575,918, filed on Sep. 27, 2001. 
BACKGROUND OF THE INVENTION 
The blood D-dimer assay is another diagnostic method 
that has become available for commercial use. The D-dimer 
protein fragment is formed when fibrin is cleaved by plas-
min and therefore produced naturally whenever clots form in 
the body. As a result, the D-dimer assay is extremely 
sensitive for the presence of a pulmonary embolism but is 
very nonspecific. In other words, if the D-dimer assay is 
normal, the clinician has a reasonably high degree of cer-
tainty that no pulmonary embolism is present. However, 
10 
many studies have shown a D-dimer assay is only normal in 
less than 113 of patients and thus produces a high degree of 
false positives. As a result, the D-dimer assay does not 
obviate formal pulmonary vascular imaging in most patients 
1. Field of Invention 15 with symptoms of a pulmonary embolism. 
The present invention relates generally to improvements In an attempt to increase the accuracy of diagnostic, 
physicians have recently turned to methods which can 
produce an image of a potentially afflicted lung. One such 
method is a nuclear perfusion study which involves the 
in technology used in the field of vascular occlusions of the 
respiratory system, and more particularly to non-invasive 
devices and methods for the diagnosis of a pulmonary 
embolism and related disorders. 
2. Description of Prior Art 
A pulmonary embolism occurs when an em bolus becomes 
lodged in lung arteries, thus blocking blood flow to lung 
tissue. An embolus is usually a blood clot, known as a 
thrombus, but may also comprise fat, amniotic fluid, bone 
marrow, tumor fragments, or even air bubbles that block a 
blood vessel. Unless treated promptly, a pulmonary embo-
lism can be fatal. In the United States alone, around 600,000 
cases occur annually, 10 percent of which result in death. 
20 injection of a small amount of radioactive particles into a 
vein. The radioactive particles then travel to the lungs where 
they highlight the perfusion of blood in the lung based upon 
whether they can penetrate a given area of the lung. While 
normal results can indicate that a patient lacks a pulmonary 
25 embolism, an abnormal scan does not necessarily mean that 
a pulmonary embolism is present. Nuclear perfusion is often 
performed in conjunction with a lung ventilation scan to 
optimize results. 
The detection of a pulmonary embolism is extremely 
difficult because signs and symptoms can easily be attributed 
to other conditions and symptoms may vary depending on 
the severity of the occurrence. Frequently, a pulmonary 
embolism is confused with a heart attack, pneumonia, hyper-
ventilation, congestive heart failure or a panic attack. In 
other cases, there may be no symptoms at all. 
During a lung ventilation scan, the patient inhales a 
30 gaseous radioactive material. The radioactive material 
becomes distributed throughout the lung's small air sacs, 
known as alveoli, and can be imaged. By comparing this 
scan to the blood supply depicted in the perfusion scan, a 
physician may be able to determine whether the person has 
35 
a pulmonary embolism based upon areas that show normal 
ventilation but lack sufficient perfusion. Nevertheless, a 
perfusion scan does not always provide clear evidence that 
a pulmonary embolism is the cause of the problem as it often 
yields indeterminate results in as many as 70% of patients. 
40 
Often, a physician must first eliminate the possibility of 
other lung diseases before determining that the symptoms, if 
any, are caused by a pulmonary embolism. Traditional 
diagnostic methods of testing involve blood tests, chest 
X-rays, and electrocardiograms. These methods are typically 
more effective in ruling out other possible reasons than for 
actually diagnosing a pulmonary embolism. For example, a 
chest x-ray may reveal subtle changes in the blood vessel 
patterns after an embolism and signs of pulmonary infarc- 45 
tion. However, chest x-rays often show normal lungs even 
when an embolism is present, and even when the x-rays 
show abnormalities they rarely confirm a pulmonary embo-
lism. Similarly, an electrocardiogram may show abnormali-
ties, but it is only useful in establishing the possibility of a 50 
pulmonary embolism. 
As a pulmonary embolism alters the ability of the lungs to 
oxygenate the blood and to remove carbon dioxide from the 
blood, one method of diagnosing the condition involves 
taking a specimen of arterial blood and measuring the partial 55 
pressure of oxygen and carbon dioxide in the arterial blood 
(i.e., an arterial blood gas analysis). Although a pulmonary 
embolism usually causes abnormalities in these measure-
ments, there is no individual finding or combination of 
findings from the arterial blood gas analysis that allows 60 
either a reliable way to exclude or specific way of diagnos-
ing pulmonary embolism. In particular, at least 15-20% of 
patients with a documented pulmonary embolism have nor-
mal oxygen and carbon dioxide contents of the arterial 
blood. Accordingly, the arterial blood analysis cannot reli- 65 
ably include or exclude the diagnosis of a pulmonary 
embolism. 
Pulmonary angiograms are popular means of diagnosing 
a pulmonary embolism, but the procedure poses some risks 
and is more uncomfortable than other tests. During a pul-
monary angiogram, a catheter is threaded into the pulmo-
nary artery so that iodine dye can be injected into the 
bloodstream. The dye flows into the regions of the lung and 
is imaged using x-ray technology, which would indicate a 
pulmonary embolism as a blockage of flow in an artery. 
Pulmonary angiograms are more useful in diagnosing a 
pulmonary embolism than some of the other traditional 
methods, but often present health risks and can be expen-
sive. Although frequently recommended by experts, few 
physicians and patients are willing to undergo such an 
invasive procedure. 
Spiral volumetric computed tomography is another diag-
nostic tool that has recently been proposed as a less invasive 
test which can deliver more accurate results. The proce-
dure's reported sensitivity has varied widely, however, and 
it may only be useful for diagnosing an embolism in central 
pulmonary arteries as it is relatively insensitive to clots in 
more remote regions of the lungs. 
These pulmonary vascular imaging tests have several 
disadvantages in common. Nearly all require ionizing radia-
tion and invasiveness of, at a minimum, an intravenous 
catheter. The imaging tests also typically involve costs of 
more than $1,000 for the patient, take more than two hours 
to perform, and require special expertise such as a trained 
US 7,344,497 B2 
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technician to perform the tests and acquire the images and a 
board-certified radiologist to interpret the images. Notably, 
none are completely safe for patients who are pregnant. As 
a result of these shortcomings, the imaging procedures are 
not available in many outpatient clinic settings and in many 
portions of third world countries. 
OBJECTS AND ADVANTAGES 
It is a principal object and advantage of the present 
invention to provide physicians with an instrument for 
non-invasively diagnosing pulmonary vascular occlusions. 
It is an additional object and advantage of the present 
invention to provide physicians with an instrument that 
accurately diagnoses pulmonary vascular occlusions. 
It is a further object and advantage of the present inven-
tion to provide an instrument for measuring and interpreting 
pulmonary test data. 
4 
Once the inhaled air 18 reaches the alveoli 16, the oxygen 
content decreases while the carbon dioxide content increases 
until an equilibrium with blood gas levels in the pulmonary 
arteries 12 is reached. The inhaled air 18 is then, as seen in 
FIG. 2, expired as exhaled air 20. Exhaled air 20 from 
properly functioning lungs typically contains a partial pres-
sure of oxygen of about eighty (80) torr and a partial 
pressure of carbon dioxide of about forty ( 40) torr. 
FIG. 3 depicts the functioning of a respiratory system 
10 afllicted with a pulmonary embolism 22 which, as an 
example, occludes blood flow to an afllicted lung 24. As a 
result, there is a reduction in the number of alveoli 16 that 
participate in gas exchange. This volume of space available 
in the alveoli 16 that is lost from participation is commonly 
15 referred to as alveolar deadspace. Due to the deadspace and 
loss of total alveolar volume available for gas exchange, 
afllicted lung 24 does not exchange gases as readily as the 
healthy lung 10. Accordingly, exhaled air 26 contains a 
Other objects and advantages of the present invention will 20 
in part be obvious, and in part appear hereinafter. 
higher partial pressure of oxygen and lower partial pressure 
of carbon dioxide than air exhaled from a healthy lung. In 
the example depicted in FIG. 3, exhaled air 26 exiting the 
SUMMARY OF THE INVENTION 
In accordance with the foregoing objects and advantages, 
the present invention provides a device and method for 
non-invasively diagnosing a pulmonary embolism. The 
device of the present invention comprises a breathing tube 
having sensors for measuring the flow of air into and out of 
a patient's lungs while a remote data processing unit inter-
connected to the breathing tube simultaneously determines 
the oxygen and carbon dioxide concentrations. The device 
further includes a display screen for visually graphing the 
resulting calculations and providing a visual means for 
determining the likelihood that a pulmonary embolism is 
present based upon a change in measured gas concentra-
tions. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is an illustration of a respiratory system during 
inhalation. 
FIG. 2 is an illustration of a respiratory system during 
exhalation. 
respiratory system contains a partial pressure of oxygen of 
about eighty-five (85) torr and a partial pressure of carbon 
dioxide of about twenty (20) torr. Thus, the ratio of carbon 
25 dioxide to oxygen in exhaled air 26 from afllicted lung 24 
(i.e., 20:85) is smaller than the ratio in exhaled air 20 from 
healthy lung 10 (i.e., 40:80) as seen in FIG. 2. 
As seen in FIG. 4, a system 28 for measuring and 
diagnosing pulmonary disorders comprises a measuring unit 
30 30 in combination with a data processing unit 50 and a 
display screen 60. Measuring unit 30 determines the overall 
flow of air inhaled into and exhaled out of the lungs while 
simultaneously determining the partial pressure of oxygen 
and carbon dioxide. Data processing unit 50 computes the 
35 concentrations of carbon dioxide, oxygen, and nitrogen from 
the partial pressures and determines the ratio of carbon 
dioxide to oxygen from the raw data obtained by measuring 
unit 30. The ratio of carbon dioxide to oxygen is then plotted 
against expired volume on display screen 60. By comparing 
40 the carbon dioxide ratios to average readings, the likelihood 
that a given patient has a pulmonary embolism can be 
determined. 
FIG. 3 is an illustration of a respiratory system afllicted 45 
with a pulmonary vascular occlusion during exhalation. 
Measuring unit 30 comprises a patient mouthpiece 32 
connected in fluid communication to a breathing tube 34 
having an open end 42 through which air can be inhaled or 
exhaled. Measuring unit 30 further comprises three sensors; 
a pneumotach 36, a capnometer 38, and an oxygen monitor 
40. The three sensors are situated in series and in-line with 
breathing tube 34 for simultaneously measuring the flow, 
carbon dioxide, and oxygen levels of inhaled and exhaled 
air. Infrared and paramagnetic type sensors are preferred 
FIG. 4 is a schematic representation of the system of the 
present invention. 
FIG. 5 is a perspective view of an attachment to the 50 
invention. 
FIG. 6 is an illustration of a display screen readout. 
DETAILED DESCRIPTION 
Referring now to the drawing in which like reference 
numerals refer to like parts throughout, there is seen in FIG. 
1 a representation of lungs 10 free from any pulmonary 
occlusions. In healthy lungs 10, blood flows freely from the 
pulmonary arteries 12 into the capillaries 14 surrounding the 
individual alveoli 16 of the lungs 10. When inhaled air 18 is 
drawn into the lungs 10 and alveoli 16, oxygen is transferred 
from the inhaled air 18 to the blood stream and carbon 
dioxide is transferred out. Inhaled air 18 typically contains 
an oxygen partial pressure of approximately one hundred 
(100) torr and a carbon dioxide partial pressure of zero (0) 
torr. 
respectively. Sensors using spectrometric techniques may 
also work for both oxygen and carbon dioxide measure-
ments providing they can supply data with rapid enough 
55 response time for breath-to-breath, real-time plotting. The 
mainstream technique for measuring the inhaled or exhaled 
air is preferred, but the sidestream technique may also be 
effective. 
As seen in FIG. 5, a T-piece adaptor 70 may optionally be 
60 provided at open end 42 of breathing tube 34 for use with 
patients that are oxygen dependant. T-piece adapter 70 
contains an inlet valve 72 and an outlet valve 74 which 
properly direct the passage of inhaled and exhaled air 
through the breathing tube 34. By connecting an oxygen 
65 dependant patient's supply to the intake valve 72, inhaled air 
can first be passed through the three sensors 36, 38, 40 to 
establish baseline readings of the oxygen and carbon dioxide 
US 7,344,497 B2 
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concentrations for comparison to exhaled air, since an 
oxygen dependent patient receives air that has different 
concentrations than present in ambient air. 
6 
Data processing unit 50 comprises a commercially avail-
able computer processor programmed with software for the 
interpretation of the data obtained from measuring unit 30 
and background comparison data. Software can be specifi-
cally developed to perform the necessary calculations to 
determine the partial pressures and carbon dioxide to oxygen 
ratios or software can optionally be purchased commercially 
and, if necessary, modified to run the appropriate algorithms. 
After additional research, the background comparison data 
can be updated based on data obtained from use of the 
invention to further refine expected normal values. 
patient inhales and exhales the pneumotach flow sensor 36, 
capnometer 38, and oxygen monitor 40 perform their 
respective readings, which are then electrically transmitted 
via wires or cabling to data processing unit 50. The pro-
grammable software loaded into data processing unit 50 
convert the measurements into volume and concentration 
readings, calculate the carbon dioxide to oxygen ratio, and 
display this ratio on screen 60 in the form of a graph against 
the volume of air expired. Readings may be optimized by 
10 
requiring the patient to hold in inhaled air for several 
heartbeats before exhaling through the mouthpiece 32 of the 
measuring unit 30. It has been determined through testing 
that patients without a pulmonary embolism will normally 
Display screen 60 comprises a cathode ray tube, plasma 
screen, or other visual display for displaying computerized 
data. Screen 60 can optionally display graphs representing 
predetermined reference or background data for test popu-
lations against which the current readings can be plotted for 
15 have a carbon dioxide to oxygen ratio of 0.30 or greater 
while patients with a pulmonary embolism will have a 
carbon dioxide to oxygen ratio of 0.25 or less. 
a visual comparison. In addition to displaying the carbon 20 
dioxide to oxygen ratios as a function of time calculated by 
data processing unit 50, screen 60 may optionally display a 
plot of the expired oxygen and carbon dioxide partial 
pressures. Using this display, a physician may estimate the 
efficiency of alveolar ventilation in patients with acute 25 
respiratory distress syndromes to assist in deciding the 
mechanical ventilation settings. 
In addition to the three primary sensors 36, 38, 40, data 
processing unit 50 may optionally be connected to a pulse 
oximeter 44 that measures arterial oxygen saturation of 30 
hemoglobin in the arterial blood. From these data, and the 
additional measurement of pH and hemoglobin concentra-
tion in a peripheral venous blood sample, the cardiac output 
of the patient can be calculated according to the Fick 
equation. In order to perform the Fick equation, the average 35 
total oxygen consumed, the arterial oxygen content and 
venous oxygen content must be determined. The average 
total oxygen consumed can be determined from the oxygen 
tension and flow curves over a predetermined time period. 
For the purposes of determining cardiac output, a one minute 40 
time period is sufficient. The arterial oxygen content can be 
estimated by multiplying the arterial oxygen saturation 
(measured by pulse oximeter 44) by the hemoglobin con-
centration (determined from the venous blood sample). The 
venous oxygen content can be calculated by mathematical 45 
manipulation of the nadir (mean lowest) oxygen tension 
measured during deep expiration (in an awake patient) or a 
sign exhalation (in a mechanically ventilated patient) over 
the predetermined time period. From the nadir oxygen 
tension, venous oxygen saturation can be estimated accord- 50 
ing to published oxygen binding curves for the measured 
pH. The venous oxygen content is then calculated by mul-
tiplying the venous oxygen saturation by the venous hemo-
globin (measured from the venous blood sample). Once 
these calculations have been made, the cardiac output is 55 
determined by dividing the total oxygen consumed by the 
difference between the arterial oxygen content and the 
venous oxygen content. The algorithm for the Fick calcu-
lation can be programmed into the data processing unit 
software and the results displayed on screen 60. The cardiac 60 
output measurement is useful for assisting the physician in 
determining the success or failure of treatment designed to 
relieve pulmonary vascular obstructions, or to treat circula-
tory shock. 
Device 28 is used by having a patient breathe (inhale and 65 
exhale a predetermined number of times in succession) 
through mouthpiece 32 of the measuring unit 30. As the 
Device 28 may also be used for the detection of whole-
body oxygen consumption and determination of the 
adequacy of oxygen delivery during resuscitation from 
shock. During conditions of systemic inflanimation the body 
will extract oxygen at higher levels than normal, resulting in 
an increase in the partial pressure of carbon dioxide-to-
oxygen ratio in exhaled air. By using T-piece 70 in the 
manner explained above, the concentration of the oxygen 
provided to the patient and the concentration of the oxygen 
exhaled can be determined. As illustrated in FIG. 6, when 
the level of oxygen delivery (i.e., the amount provided 
minus the amount exhaled) observed at two inspired oxygen 
concentrations reaches normal levels a physician has visual 
conformation that the resuscitation performed is adequate. 
One method of determining the adequacy of resuscitation is 
to determine oxygen delivery at both relatively low fixed 
concentrations of oxygen and at relatively high fixed con-
centration. Relatively low concentrations include from about 
twenty-one to thirty percent (21-30%) oxygen and relatively 
high oxygen concentrations involve about forty-five to one 
hundred percent ( 45-100%) oxygen. The difference between 
oxygen delivery at relatively low concentrations verses 
relatively high concentrations can be compared against a 
nomogram for healthy patients of similar age, body mass, 
body mass index, and gender and used to assess the 
adequacy of fluid and vasopressor resuscitation. 
Data processing unit 50 can additionally be programmed 
to display on screen 60 any of the individual measurements 
taken by sensors 36, 38, 40, and 44, or combinations thereof 
for diagnostic purposes. For example, a plot of the expired 
carbon dioxide and oxygen concentration over time could be 
used to estimate the efficiency of alveolar ventilation in 
patients with acute respiratory distress syndrome. Addition-
ally, the plotted data from sensors 36, 38, 40, and 44 could 
be used to assist in deciding how to properly adjust mechani-
cal ventilators setting, such as the degree of positive end-
expiratory pressure, minute ventilation, and peak inspiratory 
pressure settings, to optimize patient care. For example, data 
from sensors 36, 37, 40, and 44, can be plotted individually 
in patients who are being mechanically ventilated. By simul-
taneously plotting the partial pressures of oxygen and carbon 
dioxide as a function of volume of each breath, the amount 
of carbon dioxide released and percentage of oxygen 
extracted can be determined. If the barometric pressure is 
known or inputted into data processing unit 50, the effi-
ciency of alveolar ventilation during each tidal volume 
breath can be calculated. This information can then be used 
to adjust mechanical ventilation to optimize alveolar effi-
ciency or breathing alveolar ventilation efficiency. 
US 7,344,497 B2 
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What is claimed is: 
1. A method of measuring the cardiac output of a patient, 
comprising the steps of: 
providing a mouthpiece to a patient; 
allowing said patient to inhale and exhale through said 
mouthpiece; 
continuously measuring oxygen partial pressures of the 
inhaled and exhaled air; 
continuously measuring the arterial oxygen saturation 
through pulse oximetry; 
measuring the pH and hemoglobin concentration of a 
venous blood sample taken from said patient; and 
calculating the cardiac output. 
2. The method of claim 1, wherein the step of calculating 
the cardiac output further comprises the steps of: 
calculating the average total oxygen consumed over a 
predetermined time period; 
calculating the arterial oxygen content as the product of 
measured arterial oxygen saturation and hemoglobin 
concentration; 
determining the lowest mean oxygen tension during expi-
ration over the predetermined time period; 
estimating the venous oxygen saturation from the mean 
lowest oxygen tension according to published oxygen 
binding curves for the measured pH; 
8 
calculating the venous oxygen content as the product of 
venous oxygen saturation and the measured hemoglo-
bin concentration; and 
dividing the average total oxygen consumed by the dif-
ference between the arterial oxygen content and venous 
oxygen content. 
3. The method of claim 2, further comprising the step of 
displaying said cardiac output on a screen. 
4. The method of claim 3, wherein said predetermined 
10 time period is about one minute. 
5. The method of claim 3, wherein said arterial oxygen 
saturation is measured by a pulse oximeter. 
6. The method of claim 3, wherein the oxygen partial 
pressures of said inhaled and exhaled air are measured by an 
15 oxygen monitor in fluid communication with said breathing 
tube. 
7. The method of claim 3, wherein the carbon dioxide 
partial pressures of said inhaled and exhaled air are mea-
sured by a capnometer in fluid communication with said 
20 breathing tube. 
8. The method of claim 1, wherein said step of calculating 
the cardiac output is performed by a data processor pro-
grammed to calculate the Fick equation. 
* * * * * 
